Enhance your knowledge with our comprehensive guide and curated study materials.
Xenobiotics = Foreign chemical substances.
Examples:
Drugs
Environmental toxins
Food additives
Main site:
Liver (smooth endoplasmic reticulum)
Goal:
Convert lipid-soluble compounds → water-soluble metabolites → excretion.
Phase I → Functionalization
Phase II → Conjugation
This chapter focuses on Phase I.
Purpose:
Introduce or expose functional groups:
–OH
–NH₂
–SH
–COOH
These reactions may:
Inactivate drugs
Activate prodrugs
Produce toxic intermediates


4
Major enzyme:
Cytochrome P450 (CYP450)
Location:
Smooth ER of hepatocytes.
Requires:
NADPH
O₂
Catalyzed by:
Cytochrome P450 monooxygenase system.
General reaction:
RH + O₂ + NADPH → ROH + H₂O
One oxygen atom incorporated into substrate.
Hydroxylation
Dealkylation
Deamination
Sulfoxidation
Barbiturate oxidation
Conversion of benzene → phenol
Drug interactions
Enzyme induction
Enzyme inhibition
Inducers:
Rifampicin, phenobarbital.
Inhibitors:
Cimetidine, erythromycin.
Occur when oxygen availability is low.
Common in:
Azo compounds
Nitro compounds
Mechanism:
Gain of electrons (reduction).
Example:
Chloramphenicol reduction.
Often occur in:
Liver
Intestinal bacteria
Esterases and amidases split:
Ester bonds
Amide bonds
Example:
Aspirin hydrolysis.
Hemoprotein system.
Contains:
Heme iron.
Function:
Mixed function oxidase.
Can produce reactive intermediates.
Important example:
Paracetamol (acetaminophen)
Small fraction converted to:
NAPQI (toxic metabolite)
Detoxified by:
Glutathione.
Overdose → glutathione depletion → liver necrosis.


4
Age
Genetic polymorphism
Nutrition
Liver disease
Drug interactions
Example:
Slow acetylators (though acetylation is Phase II, examiner may connect).
Phase I = Functionalization
Main enzyme = CYP450
Requires NADPH + O₂
Oxidation most common
Reduction under low oxygen
Toxic intermediates possible
Biotransformation is chemical modification — not always detoxification.
Sometimes the liver makes a drug safer.
Sometimes it makes it more dangerous.
Hydrolysis breaks chemical bonds using water.
Common substrates:
Esters
Amides
Enzymes:
Esterases
Amidases
Example:
Aspirin → Salicylic acid
Hydrolysis often occurs in:
Liver
Plasma
Intestinal mucosa
Hydrolysis increases polarity but does not always make the compound fully water-soluble.
Purpose:
Conjugation.
Adds large polar molecules to drug.
Result:
Highly water-soluble compound → excreted in urine or bile.
Usually inactivates drug.



4
Glucuronidation
Sulfation
Acetylation
Methylation
Glutathione conjugation
Glycine conjugation
Most common Phase II reaction.
Enzyme:
UDP-glucuronyl transferase.
Location:
Smooth ER.
Adds:
Glucuronic acid.
Example:
Bilirubin conjugation.
Important clinically:
Newborns have low glucuronyl transferase → risk of kernicterus.
Enzyme:
Sulfotransferase.
Adds:
Sulfate group.
Important for:
Steroid hormones.
Enzyme:
N-acetyl transferase (NAT).
Substrates:
Isoniazid
Sulfonamides
Hydralazine
Genetic polymorphism:
Slow acetylators
Fast acetylators
Slow acetylators → higher toxicity risk.
Note:
Acetylation does NOT always increase water solubility significantly.
Adds methyl group.
Usually reduces activity.
Example:
Catecholamines.
Protective mechanism.
Enzyme:
Glutathione-S-transferase.
Important in detoxifying:
Reactive oxygen species
Toxic intermediates (e.g., NAPQI from paracetamol)
Glutathione depletion → toxicity.
Now the export system.
After Phase II conjugation, metabolites must be transported out of cells.
Phase III involves:
ATP-dependent transporters.
Example:
P-glycoprotein (MDR transporter)
Location:
Liver canalicular membrane
Kidney
Intestinal epithelium
Function:
Efflux of drugs into bile or urine.
4
Phase I:
Functionalization (oxidation, reduction, hydrolysis)
Phase II:
Conjugation (glucuronide, sulfate, acetyl, etc.)
Phase III:
Transport and excretion
Neonatal jaundice → low glucuronidation
Slow acetylators → drug toxicity
Paracetamol overdose → glutathione depletion
Multidrug resistance → P-glycoprotein overexpression
Hydrolysis breaks esters/amides
Phase II = conjugation
Glucuronidation most common
Acetylation genetically variable
Glutathione protects against toxic metabolites
Phase III exports via ATP transporters
Biotransformation is organized chemistry.
Phase I makes the molecule reactive.
Phase II makes it soluble.
Phase III sends it away.
Q1. What are xenobiotics?
Foreign chemical substances such as drugs, toxins, and pollutants.
Q2. What is the main site of biotransformation?
Liver (smooth endoplasmic reticulum).
Q3. What is the purpose of biotransformation?
Convert lipid-soluble compounds into water-soluble metabolites for excretion.
Q4. What are the three phases of drug metabolism?
Phase I (functionalization), Phase II (conjugation), Phase III (transport/excretion).
Q5. What is the purpose of Phase I reactions?
Introduce or expose functional groups.
Q6. What is the major enzyme system in Phase I?
Cytochrome P450.
Q7. Where is CYP450 located?
Smooth ER of hepatocytes.
Q8. What cofactors are required for oxidative reactions?
NADPH and O₂.
Q9. Name three types of Phase I reactions.
Oxidation, reduction, hydrolysis.
Q10. What is the most common Phase I reaction?
Oxidation.
Q11. What is the general reaction of CYP450?
RH + O₂ + NADPH → ROH + H₂O.
Q12. What is enzyme induction?
Increased enzyme activity due to certain drugs.
Q13. Name one enzyme inducer.
Rifampicin.
Q14. Name one enzyme inhibitor.
Cimetidine.
Q15. When do reductive reactions commonly occur?
Under low oxygen conditions.
Q16. Name a compound undergoing reduction.
Azo or nitro compounds.
Q17. What bonds are broken during hydrolysis?
Ester and amide bonds.
Q18. Name enzymes involved in hydrolysis.
Esterases and amidases.
Q19. Give one example of hydrolysis reaction.
Aspirin → Salicylic acid.
Q20. What is the purpose of Phase II reactions?
Increase water solubility by conjugation.
Q21. What is the most common Phase II reaction?
Glucuronidation.
Q22. Which enzyme performs glucuronidation?
UDP-glucuronyl transferase.
Q23. Why are newborns prone to kernicterus?
Low glucuronyl transferase activity.
Q24. What is acetylation?
Addition of acetyl group via N-acetyl transferase.
Q25. What is special about acetylation?
Shows genetic polymorphism (slow and fast acetylators).
Q26. Name one drug that undergoes acetylation.
Isoniazid.
Q27. What is glutathione conjugation?
Detoxification of reactive intermediates.
Q28. Which enzyme catalyzes glutathione conjugation?
Glutathione-S-transferase.
Q29. What happens in paracetamol overdose?
Glutathione depletion → liver toxicity.
Q30. What is Phase III reaction?
Transport of conjugated metabolites out of cells.
Q31. Which transporter is involved in Phase III?
P-glycoprotein.
Q32. Phase III transport requires what?
ATP.
Q33. Where are Phase III transporters found?
Liver, kidney, intestine.
Q34. Can Phase I reactions sometimes produce toxic metabolites?
Yes.
Q35. Which metabolite of paracetamol is toxic?
NAPQI.
Q36. Which antioxidant neutralizes NAPQI?
Glutathione.
Q37. What is enzyme induction effect on drug levels?
Decreases drug levels by increasing metabolism.
Q38. What is enzyme inhibition effect on drug levels?
Increases drug levels.
Q39. Which phase is usually responsible for drug inactivation?
Phase II.
Q40. Are Phase II reactions always inactivating?
Mostly, but not always.
Q41. Which phase introduces functional groups?
Phase I.
Q42. Which phase increases polarity the most?
Phase II.
Q43. Which phase involves ATP-dependent transport?
Phase III.
Q44. Which phase shows genetic polymorphism commonly?
Acetylation in Phase II.
Q45. What is the overall goal of detoxification?
Enhance elimination of xenobiotics.
A. Endogenous hormones
B. Foreign chemical substances
C. Vitamins
D. Enzymes
A. Kidney
B. Brain
C. Liver
D. Spleen
A. Increase molecular size
B. Introduce functional groups
C. Conjugate glucuronic acid
D. Excrete drug
A. Catalase
B. Cytochrome P450
C. Transferrin
D. Pepsin
A. Mitochondria only
B. Nucleus
C. Smooth ER
D. Ribosomes
A. NADH only
B. NADPH and O₂
C. ATP only
D. FAD only
A. RH + H₂O → ROH
B. RH + O₂ + NADPH → ROH + H₂O
C. RH + CO₂ → RCOOH
D. RH + ATP → ROH
A. Reduction
B. Oxidation
C. Conjugation
D. Acetylation
A. In high oxygen state
B. In low oxygen state
C. Only in kidney
D. Only in plasma
A. Double bonds
B. Ester and amide bonds
C. Peptide bonds only
D. Disulfide bonds
A. Oxidation
B. Hydrolysis
C. Conjugation
D. Methylation
A. Functionalization
B. Conjugation
C. Reduction
D. Oxidation
A. Sulfation
B. Acetylation
C. Glucuronidation
D. Methylation
A. Sulfotransferase
B. UDP-glucuronyl transferase
C. Acetyl transferase
D. Catalase
A. Hemolysis
B. Kernicterus
C. Rickets
D. Pellagra
A. NAT
B. CYP450
C. GST
D. UGT
A. Glucuronidation
B. Acetylation
C. Sulfation
D. Reduction
A. Drug toxicity
B. Rapid elimination
C. Hypoglycemia
D. Hypocalcemia
A. Hyperglycemia
B. Reactive toxic intermediates
C. Iron overload
D. Ketosis
A. NAPQI
B. Bilirubin
C. Acetyl-CoA
D. Lactate
A. Renal failure
B. Liver necrosis
C. Hypothyroidism
D. Anemia
A. Conjugation
B. Oxidation
C. ATP-dependent transport
D. Hydrolysis
A. Oxidase enzyme
B. Conjugating enzyme
C. Efflux transporter
D. Hormone
A. NADPH
B. Oxygen
C. ATP
D. FAD
A. Increased drug levels
B. Decreased drug metabolism
C. Increased drug metabolism
D. No effect
A. Faster drug clearance
B. Increased drug levels
C. Decreased toxicity
D. No change
A. Phase I
B. Phase II
C. Phase III
D. All phases
A. Acetyl group
B. Methyl group
C. Sulfate group
D. Glucose
A. Inactivate drug
B. Increase water solubility
C. Modify drug
D. Affect activity
A. Bone
B. Plasma
C. Brain
D. Thyroid
A. Lungs
B. Sweat only
C. Urine or bile
D. Skin
A. Oxidation
B. Conjugation
C. Reduction
D. Hydrolysis
A. Copper
B. Iron
C. Zinc
D. Cobalt
A. Hydrolysis enzyme
B. CYP450 system
C. Transferase
D. Peptidase
A. CYP inhibitor
B. CYP inducer
C. Transferase inhibitor
D. Sulfotransferase inhibitor
A. CYP inducer
B. CYP inhibitor
C. Conjugating enzyme
D. Transporter
A. Oxidation
B. Reduction
C. Glucuronidation
D. Acetylation
A. Phase I
B. Phase II
C. Phase III
D. None
A. Glucuronidation
B. Glutathione conjugation
C. Acetylation
D. Methylation
A. Aspirin
B. Glucose
C. Cholesterol
D. Thyroxine
A. Inactivate drug
B. Activate prodrug
C. Produce toxic intermediates
D. All of the above
A. Transferrin
B. CYP450
C. Pepsin
D. Renin
A. Phase I
B. Phase II
C. Phase III
D. Hydrolysis
A. Increased CYP450
B. P-glycoprotein overexpression
C. Increased acetylation
D. Decreased glucuronidation
A. Kidney
B. Liver
C. Heart
D. Muscle
A. Reduction
B. Hydrolysis
C. Oxidation
D. Methylation
A. Lipid solubility
B. Hydrophobicity
C. Reactivity
D. Molecular weight drastically
A. Phase I
B. Phase II
C. Phase III
D. Digestion
A. Phase I
B. Phase II
C. Phase III
D. Hydrolysis
A. Drug activation
B. Increase lipid solubility
C. Facilitate excretion
D. Produce ROS
B
C
B
B
C
B
B
B
B
B
B
B
C
B
B
A
B
A
B
A
B
C
C
C
C
B
A
C
B
B
C
B
B
B
B
B
C
B
B
A
D
B
C
B
B
C
C
B
C
C
Q1. What are xenobiotics?
Foreign chemical substances not normally produced in the body.
Q2. What is biotransformation?
Chemical modification of xenobiotics to increase water solubility for excretion.
Q3. Where does most biotransformation occur?
Liver.
Q4. Which cellular organelle is mainly involved?
Smooth endoplasmic reticulum.
Q5. What are the three phases of drug metabolism?
Phase I – Functionalization
Phase II – Conjugation
Phase III – Transport and excretion
Q6. What is the purpose of Phase I reactions?
To introduce or expose functional groups.
Q7. Name the major enzyme system in Phase I.
Cytochrome P450.
Q8. Where is Cytochrome P450 located?
Smooth ER of hepatocytes.
Q9. What cofactors are required for CYP450 reactions?
NADPH and oxygen.
Q10. Write the general oxidation reaction.
RH + O₂ + NADPH → ROH + H₂O.
Q11. What types of reactions occur in Phase I?
Oxidation, reduction, hydrolysis.
Q12. Which is the most common Phase I reaction?
Oxidation.
Q13. Can Phase I reactions produce toxic metabolites?
Yes.
Q14. What is mixed-function oxidase?
Another name for the CYP450 system.
Q15. What metal is present in Cytochrome P450?
Iron (heme).
Q16. What is enzyme induction?
Increased synthesis of CYP450 enzymes.
Q17. Name one CYP450 inducer.
Rifampicin.
Q18. Name one CYP450 inhibitor.
Cimetidine.
Q19. What is the clinical effect of enzyme inhibition?
Increased plasma drug concentration.
Q20. When do reductive reactions occur commonly?
Under low oxygen conditions.
Q21. Give one example of a compound undergoing reduction.
Azo compounds.
Q22. What bonds are broken during hydrolysis?
Ester and amide bonds.
Q23. Name enzymes involved in hydrolysis.
Esterases and amidases.
Q24. Give one example of hydrolysis reaction.
Aspirin → Salicylic acid.
Q25. What is the purpose of Phase II reactions?
Conjugation to increase water solubility.
Q26. Which Phase II reaction is most common?
Glucuronidation.
Q27. Which enzyme catalyzes glucuronidation?
UDP-glucuronyl transferase.
Q28. Why are neonates prone to kernicterus?
Low glucuronyl transferase activity.
Q29. What is acetylation?
Addition of an acetyl group via N-acetyl transferase.
Q30. What is unique about acetylation?
Genetic polymorphism (slow and fast acetylators).
Q31. Name one drug metabolized by acetylation.
Isoniazid.
Q32. What is glutathione conjugation?
Detoxification of reactive intermediates by glutathione.
Q33. Which enzyme catalyzes glutathione conjugation?
Glutathione-S-transferase.
Q34. What is the toxic metabolite of paracetamol?
NAPQI.
Q35. How is NAPQI detoxified?
By glutathione conjugation.
Q36. What happens in paracetamol overdose?
Glutathione depletion → liver necrosis.
Q37. What is Phase III reaction?
ATP-dependent transport of metabolites out of cells.
Q38. Name one Phase III transporter.
P-glycoprotein.
Q39. Where is P-glycoprotein found?
Liver, intestine, kidney.
Q40. What is its function?
Efflux of drugs into bile or urine.
Q41. What clinical condition is associated with P-glycoprotein overexpression?
Multidrug resistance in cancer.
Q42. Which phase increases drug polarity slightly?
Phase I.
Q43. Which phase increases water solubility markedly?
Phase II.
Q44. Which phase requires ATP?
Phase III.
Q45. Can biotransformation ever activate a drug?
Yes, in case of prodrugs.
Q46. What happens to lipid-soluble drugs without biotransformation?
They accumulate in tissues.
Q47. Which phase shows genetic variability commonly tested in exams?
Acetylation in Phase II.
Q48. Why is liver disease clinically important in drug metabolism?
Reduced biotransformation → drug toxicity.
Q49. Which antioxidant is crucial in detoxification?
Glutathione.
Q50. What is the ultimate aim of detoxification?
To facilitate elimination of xenobiotics.
Get the full PDF version of this chapter.